Human T cell differentiation : basic aspects and their clinical applications

Immune recognition plays a central role in our understanding of the function of the immune system. The ability to specifically recognize foreign antigens allows selective but efficient actions of the immune system against all kinds of pathogens. This is mediated by antigen-specific receptors on B and T lymphocytes. Immunoglobulin (lg) molecules represent the antigenspecific receptors of B lymphocytes, while the T cell receptor (TeA) has this function in T lymphocytes (1). Although these two types of antigen receptors have remarkable similarities in protein structure and their encoding genes, they differ significantly in their ability to interact with antigens (1). Via their surface membrane lg (Smlg) molecules, B lymphocytes are able to recognize antigens in their native configuration either free in solution, on surfaces or on cell membranes (1). TeA molecules ofT lymphocytes can only recognize processed or degraded antigens which are physically associated with major histocompatibility complex (MHC) molecules (2,3). This TeA-mediated recognition is therefore called MHC-restricted antigen recognition (2,3). Expression of Smlg or TcA molecules by lymphocytes is acquired during lymphoid differentiation via several rearrangement processes in the lg or TcR genes (3-7). B lymphopoiesis mainly occurs in the bone marrow (8), while the thymus is thought to represent the main tissue compartment for T lymphopoiesis (9-11 ). During T cell differentiation in the thymus the T lymphocytes are "educated" for their future functions, i.e. T cells which recognize self antigens are eliminated (negative selection), while positive selection occurs for T cells which recognize foreign (non-self) antigens in association with self-MHC molecules (12-14). Upon recognition of a TeA-compatible antigen, T lymphocytes are activated, start to proliferate and exhibit their regulatory or cytotoxic functions (2). These T cell functions play a central role in the regulation of the immune system. The T lymphocytes probably coordinate immune processes via cellular interactions and lymphokines and in this way adjust and harmonize the actions of the immune system. The TeA consists of two chains, which are closely associated with the CD3 protein complex (TcA-CD3). Th

Elimination of ghost images in the response of PHASAR-demultiplexers

In this paper the occurrence of first-order modes in the performance of phased-array demultiplexers is investigated. It is found that they cause "ghost" images, which can be circumvented by optimising waveguide junction

A compact phased array based multi-wavelength laser

A phased-array-based multiwavelength laser with InGaAsP active layer has been fabricated in a simple ridge waveguide structure with nine channels spaced by 400 GHz around 1.55 mu m on an area of 3.5*3*2.5 mm/sup 2/. Simultaneous dual channel operation is demonstrate

Basic helix-loop-helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells

T-cell receptor (TCR) gene rearrangements are mediated via V(D)J recombination, which is strictly regulated during lymphoid differentiation, most probably through the action of specific transcription factors. Investigated was whether cotransfection of RAG1 and RAG2 genes in combination with lymphoid transcription factors can induce TCR gene rearrangements in nonlymphoid human cells. Transfection experiments showed that basic helix-loop-helix transcription factors E2A and HEB induce rearrangements in the TCRD locus (Ddelta2-Ddelta3 and Vdelta2-Ddelta3) and TCRG locus (psi Vgamma7-Jgamma2.3 and Vgamma8-Jgamma2.3). Analysis of these rearrangements and their circular excision products revealed some peculiar characteristics. The Vdelta2-Ddelta3 rearrangements were formed by direct coupling without intermediate Ddelta2 gene segment usage, and most Ddelta2-Ddelta3 recombinations occurred via direct coupling of the respective upstream and downstream recombination signal sequences (RSSs) with deletion of the Ddelta2 and Ddelta3 coding sequences. Subsequently, the E2A/HEB-induced TCR gene recombination patterns were compared with those in early thymocytes and acute lymphoblastic leukemias of T- and B-lineage origin, and it was found that the TCR rearrangements in the transfectants were early (immature) and not necessarily T-lineage specific. Apparently, some parts

Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at elapse of childhood precursor-B–ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease

Immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements are excellent patient-specific polymerase chain reaction (PCR) targets for detection of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL), but they might be unstable during the disease course. Therefore, we performed detailed molecula

Redefining non-inferiority in anamnestic antibody responses using the mean increase of log-transformed antibody titers after revaccination: secondary analysis of a randomized controlled rabies vaccination trial

Non-inferiority in the anamnestic antibody response is conventionally determined by comparing seroconversion rates after revaccination. However, this approach is inadequate in the case of high pre-booster antibody titers. Therefore, we propose an alternative method to determine non-inferiority of booster responses. We used anonymized data from a randomized controlled trial (NCT01388985; EudraCT 2011-001612-62) in 500 adults, comparing a two-visit primary vaccination schedule (two intradermal 0.1 mL rabies vaccine doses on day 0 and 7) with a three-visit schedule (single intradermal 0.1 mL dose on day 0, 7, and 28). Participants were revaccinated intradermally (single dose) 1 to 3 years later. Rabies virus neutralizing antibody titers were measured on day 0 and 7 after revaccination. After log(3)-transformation of antibody titers, the mean increase in titers after revaccination was compared between schedules. Non-inferiority was defined as the lower bound of the two-sided 95% confidence interval not exceeding -0.369. Four hundred and ten participants fulfilled the inclusion criteria. The mean increase in log(3) titer was 2.21 and 2.31 for the two-visit and three-visit schedule, respectively. The difference between these increases was -0.10 [-0.28, 0.08], meeting the non-inferiority criterion. In conclusion, comparing mean increases in log-transformed titers after revaccination appears to be a feasible and more informative method of studying non-inferiority regarding the anamnestic antibody response.Development and application of statistical models for medical scientific researc

The role of ARNT in liver and myeloid cell function

Aryl hydrocarbon receptor nuclear translocator (ARNT) is a transcription factor which acts as a general partner for members of the bHLH/PAS family of transcription factors. To investigate the effect of long term ARNT deletion in hepatocyte and myeloid cells, we created 2 lines of mice with ARNT deletion in these cells. Mice lacking hepatocyte ARNT had impaired glucose tolerance, increased gluconeogenesis, decreased ATP and increased post-prandial serum triglycerides. However, in contrast to type 2 diabetes (T2D) hepatic ARNT deletion resulted in decreased liver steatosis. Importantly, these changes became non-significant after high fat diet (HFD). Decreased ARNT in myeloid cells led to decreased cytokine expression, decreased phagocytosis, decreased bactericidal activity, impaired response to infection, and impaired wound healing. Again, the phenotype of impaired wound healing equilibrated in a diabetic milieu. In addition mice lacking ARNT in myeloid cells displayed impaired glucose tolerance on HFD and paradoxically increased liver inflammation. In human monocytes ARNT mRNA correlated negatively with serum cytokine levels of IL-6, IL-8, MCP-1 and TNF-α. This data demonstrates that ARNT has important roles in hepatocyte and myeloid cell function and suggests that modulation of this transcription factor could be used in future therapy for diabetes and disorders of immune function